Jeffrey Goldberg
Effective May 22, 2025, the board of directors (the “Board”) of Modular Medical, Inc. (the “Company”) appointed Jeffrey Goldberg as a member of the Board.
Highest-materiality recent filing
Modular Medical grants 15,892 stock options to CEO/CFO and COO
11,218 options awarded to Chairman/President/CFO Paul DiPerna.
Modular Medical prices $3.4M offering of 750k shares at $4.50 each
Gross proceeds ~$3.4M from sale of 750,000 shares; closing expected April 21, 2026.
Modular Medical regains Nasdaq minimum bid price compliance as of April 14, 2026
Received Nasdaq letter on April 15, 2026 confirming compliance with $1.00 minimum bid price requirement.
Modular Medical announces 1-for-30 reverse stock split to regain Nasdaq compliance
Reverse split effective 5:30am ET March 31, 2026; trading on split-adjusted basis under MODD symbol.
Modular Medical lays off 29% of workforce to cut annual costs by $3.4M
Layoff of 20 positions, representing ~29% of total workforce, effective March 12, 2026.
Modular Medical raises $12M via public offering of 68M shares and warrants
Gross proceeds ~$12M from sale of 68,098,000 shares (or pre-funded warrants) and 68,098,000 warrants at $0.1762/unit.
$350,000 revolving credit facility from CEO James E. Besser (Manchester Explorer, L.P.).
Authorized common shares increased from 100M to 250M (Proposal 3: 46.75M for, 5.04M against).
Modular Medical gets 180-day Nasdaq extension to June 29, 2026 to meet $1 bid price
Nasdaq granted 180-day extension under Rule 5810(c)(3)(A) after initial non-compliance notice on June 30, 2025.
Modular Medical raises $4.68M in underwritten public offering of stock and warrants
Offered 12,173,000 shares of common stock and warrants for 6,086,500 shares at combined price of $0.77 per unit.
Modular Medical induces warrant exercise for ~$3.7M gross; issues new warrants at premium
Warrant holders exercise ~5.5M shares at $0.68/share (10% discount to NOCP), raising $3.7M.
Modular Medical receives Nasdaq minimum bid price deficiency notice; 180-day cure period
Nasdaq notified Company of bid price deficiency: closing bid below $1.00 for 30 consecutive business days ending June 27, 2025.
Modular Medical appoints Jeff Goldberg, insulin delivery veteran, to Board
Appointed Jeff Goldberg to Board effective May 22, 2025.
Effective May 22, 2025, the board of directors (the “Board”) of Modular Medical, Inc. (the “Company”) appointed Jeffrey Goldberg as a member of the Board.
Max materiality 0.75 · Median 0.55 · Most common event other_material